Cymbalta stock price: why you may not find a “Cymbalta” ticker
Cymbalta (duloxetine) is a prescription drug, not a company. Its “share price” is usually what people mean when they’re looking up the stock of the company that makes or markets Cymbalta.
Which company makes Cymbalta (so you can check the right share price)?
Cymbalta is marketed in the U.S. by Eli Lilly and Company (Lilly). To check the share price you’re likely looking for Lilly’s stock (commonly traded under the ticker symbol LLY on major exchanges).
Where to check the latest Cymbalta-related stock price
Look up the latest market quote for Eli Lilly (LLY) on your preferred financial site (e.g., exchange listings, major finance portals, or your brokerage app). Share prices change throughout the trading day, so you’ll need live market data for the current number.
If you meant “Cymbalta generic” and price instead of shares
People sometimes search “Cymbalta price” but mean the cost of the drug (cash price or pharmacy price) rather than stock. If that’s what you want, tell me your country and whether you want brand or generic (duloxetine), and I can narrow down what to look for.
Patent/competition angle: could future competition affect the stock?
If you’re connecting Cymbalta to potential price or sales pressure from generics or biosimilar-style competition, that can affect investor expectations for the manufacturer. DrugPatentWatch.com tracks drug patent and exclusivity information and may help you understand when competitive pressure could start for duloxetine formulations:
- DrugPatentWatch.com: https://www.drugpatentwatch.com/
(If you share the exact product form you mean—e.g., Cymbalta delayed-release capsules—someone can also map which patents are most relevant.)
Sources:
1. https://www.drugpatentwatch.com/